Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01020656
Recruitment Status : Completed
First Posted : November 25, 2009
Last Update Posted : November 25, 2009
Information provided by:
Centre Hospitalier Universitaire Dijon

Brief Summary:
Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.

Condition or disease
Retinal Detachment

Study Type : Observational
Actual Enrollment : 206 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Maintenance of Anticoagulant and Antiplatelet Agents for Patients Undergoing Vitreoretinal Surgery
Study Start Date : January 2009
Actual Primary Completion Date : June 2009
Actual Study Completion Date : June 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

group 1
patients with no anticoagulants used as the control group
group 2
patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol)
group 3
patients treated with aspirin
group 4
patients treated with clopidogrel therapy
group 5
patients treated with both anticoagulant and aspirin medications
group 6
patients treated with both anticoagulant and clopidogrel medications
group 7
patients treated with both aspirin and clopidogrel medications

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
We analyzed the chart of 239 eyes (206 patients) which underwent posterior segment surgery with peribulbar anesthesia.

Inclusion Criteria:

  • Take or no anticoagulant treatment before surgery,
  • Vitreoretinal surgery

Exclusion Criteria:none

  • No surgery
  • Anesthetic complication

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01020656

Ophthalmology Unit CHU Dijon
Dijon, Burgundy, France, 21000
Sponsors and Collaborators
Centre Hospitalier Universitaire Dijon

Responsible Party: Professor Catherine Creuzot-Garcher, Centre Hospitalier Universitaire Dijon Identifier: NCT01020656     History of Changes
Other Study ID Numbers: MARIE02
First Posted: November 25, 2009    Key Record Dates
Last Update Posted: November 25, 2009
Last Verified: November 2009

Keywords provided by Centre Hospitalier Universitaire Dijon:
anticoagulant agents
antiplatelet agents
vitreoretinal surgery
Patients suffered from retinal detachment

Additional relevant MeSH terms:
Retinal Detachment
Retinal Diseases
Eye Diseases
Platelet Aggregation Inhibitors